Carlos Alban, EVP, Commercial Operations at AbbVie Inc. (ABBV), sold 113,656 shares at $45.66 ($5.2M) on 2013-05-01, disclosed to the SEC on 2013-05-03.
Scheduled sale ($5.2M) by EVP, Commercial Operations under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $45.66 | 27,320 | $1.2M | 24.0% |
| 2 | $45.68 | 27,664 | $1.3M | 24.3% |
| 3 | $45.68 | 28,122 | $1.3M | 24.7% |
| 4 | $45.68 | 30,550 | $1.4M | 26.9% |
| Total | $45.68 avg | 113,656 | $5.2M | 100% |
| Filing → |
| ABBV | SELL | 2018-03-02 | $19.1M | — | Filing → |
| ABBV | SELL | 2017-06-15 | $3.2M | — | Filing → |
| ABBV | SELL | 2017-05-08 | $2.9M | — | Filing → |